Antimicrobial resistance and Helicobacter pylori

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue 4, 1996, Pages 639-643

  Goddard, Andrew F ^a   Logan, Robert P H ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; BISMUTH; CIPROFLOXACIN; CLARITHROMYCIN; METRONIDAZOLE; NITROIMIDAZOLE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; CHRONIC GASTRITIS; EDITORIAL; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MINIMUM INHIBITORY CONCENTRATION; PATIENT COMPLIANCE; PEPTIC ULCER;

ANTI-BACTERIAL AGENTS; ANTITRICHOMONAL AGENTS; CLARITHROMYCIN; DRUG RESISTANCE, MICROBIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; METRONIDAZOLE; NITROIMIDAZOLES;

EID: 0029880401     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.4.639     Document Type: Editorial

References (26)

1. Banatvala, N., Davies, G. R., Abdi, Y., Clements, L., Rampton, D. S., Hardie, J. M. et al. (1994). High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal diseases. Gut 35, 1562-6.
2. Bell, G. D., Powell, K., Burridge, S. M., Pallecaros, A, Jones, P. H., Gant, P. W. et al. (1992). Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment isolate for metronidazole resistance. Alimentary Pharmacology and Therapeutics 6, 427-35.
3. Buckley, M., Keating, S., Xia, H., Beattie, S., Hamilton, H. & O'Morain, C. (1995). Omeprazole plus one or two antibiotics to eradicate H. pylori. Gastroenterology 108, A63.
4. Burette, A , Glupczynski, Y & De Prez, C. (1992). Evaluation of various multi-drug eradication regimens for Helicobacter pylori. European Journal of Gastroenterology and Hepatology 4, 817-24.
5. Cayla, R., Zerbib, F , Talbi, P., Mégraud, F. & Lamouliatte, H. (1995). Pre and post-treatment clarithromycin resistance of Helicobacter pylori strains: a key factor of treatment failure. Gut 37, Suppl. 1, A55.
6. DeCross, A. J., Marshall, B. J., McCallum, R. W., Hoffman, S. R., Barrett, L. J. & Guerrant, R. L. (1993). Metronidazole susceptibility testing for Helicobacter pylori: comparison of disk, broth, and a gar dilution methods and their clinical relevance. Journal of Clinical Microbiology 31, 1971-4.
7. European Study Group on Antibiotic Susceptibility of Helicobacter pylori. (1992). Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori. European Journal of Clinical Microbiology and Infectious Diseases 11, 777-81.
8. Glupczynski, Y. & Burette, A. (1990). Drug therapy for Helicobacter pylori infection, problems and pitfalls. American Journal of Gastroenterology 85, 1545-51.
9. Glupczynski, Y., Labbé, M., Hansen, W., Crokaert, F. & Yourassowsky, E. (1991). Evaluation of the E test for quantitative antimicrobial susceptibility testing of Helicobacter pylori. Journal of Clinical Microbiology 29, 2072-5.
10. Goddard, A. & Logan, R. (1995). One-week low-dose triple therapy: new standards for Helicobacter pylori treatment. European Journal of Gastroenterology and Hepatology 7, 1-3.
11. Goodwin, C. S., Blincow, E. D., Warren, J. R., Waters, T. E., Sanderson, C. R. & Easton, L. (1985). Evaluation of cultural techniques for isolating Campylobacter pyloridis from endoscopic biopsies of gastric mucosa. Journal of Clinical Pathology 38, 1127-31.
12. Goodwin, C. S., Marshall, B. J., Blincow, E. D., Wilson, D. H., Blackbourn, S & Phillips, M. (1988). Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies. Journal of Clinical Pathology 41, 207-10.
13. Hoffman, P. S., Goodwin, A., Johnsen, J & Veldhuyzen van Zanten, S. (1995). Metabolic pathways in metronidazole sensitive and resistant strains of Helicobacter pylori. Gut 37, Suppl. 1, A66
14. International Agency for Resesarch on Cancer. (1994). Schistosomes, liver flukes and Helicobacter pylori. Working Group on the Evaluation of Carcinogenic Risks to Humans Lyon. IARC 61, 177-241.
15. Karim, Q. N. & Logan, R. P. H. (1995). The epidemiology of Helicobacter pylori (H. pylori) antimicrobial resistance - preliminary findings of a national survey. Gut 37, Suppl. 2. A6
16. Lian, J. X., Carrick, J., Lee, A. & Daskalopoulos, G. (1993). Metronidazole resistance significantly affects eradication of H. pylori infection Gastroenterology 104, A133
17. Malfertheiner, P. (1993). Compliance, adverse events and antibiotic resistance in Helicobacter pylori treatment. Scandinavian Journal of Gastroenterology 28, Suppl. 196, 34-7.
18. Milne, R., Logan, R. P H., Harwood, D., Misiewicz, J. J. & Forman, D. (1995). Helicobacter pylori and upper gastrointestinal disease, a survey of gastroenterolegists in the United Kingdom. Gut 37, 314-8.
19. Moayyedi, P., Sahay, P , Tompkins, D. S. & Axon, A. T. R. (1995). Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. European Journal of Gastroenterology and Hepatology 7, 835-40.
20. Moore, R. A., Beckthold, B., Wong, S., Kureishi, A. & Bryan, L. E. (1995) Nucleotide sequence of the gyrA gene and characterisation of ciprofloxacin-resistant mutants of Helicobacter pylori. Antimicrobial Agents and Chemotherapy 39, 107-11.
21. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. (1994). Helicobacter pylori in peptic ulcer disease. Journal of the American Medical Association 272, 65-9.
22. Penston, J. G. (1994). Helicobacter pylori eradication - understandable caution but no excuse for inertia. Alimentary Pharmacology and Therapeutics 8, 369-89.
23. Rautelin, H., Kosunen, T., & Seppälä, K. (1992). Eradicating Helicobacter pylori. Lancet 339, 55.
24. Smith, M. A. & Edwards, D. I. (1995). Redox potential and oxygen concentrations as factors in the susceptibility of Helicobacter pylori to nitroheterocyclic drugs Journal of Antimicrobial Chemotherapy 35, 751-64.
25. Versalovic, J., Kibler, K., Small, S., Hachem, C. Y., Graham, D. Y. & Go, M. F. (1995). Molecular basis of clarithromycin resistance in Helicobacter pylori. Gastroenterology 108, A251.
26. Xia, H., Keane, C. T., Beattie, S. & O'Morain, C. A., (1994). Standardization of disk diffusion test and its clinical significance for susceptibility testing of metronidazole against Helicobacter pylori. Antimicrobial Agents and Chemotherapy 38, 2357-61.